The Valley Desk

NCT00859937 · Interventional trial

Dasatinib in Treating Patients With Recurrent or Metastatic Malignant Salivary Gland Tumors

Overall registry status Completed

Phase 2

Conditions Malignant Salivary Gland Neoplasm, Recurrent Salivary Gland Carcinoma, Salivary Gland Adenoid Cystic Carcinoma, Stage IV Major Salivary Gland Cancer AJCC v7

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov